CAS 70529-35-0
:Itazigrel
Description:
Itazigrel is a chemical compound classified as an antiplatelet agent, primarily used in the treatment of cardiovascular diseases. It functions by inhibiting platelet aggregation, thereby reducing the risk of thrombus formation, which is crucial in conditions such as acute coronary syndrome. The compound is characterized by its specific mechanism of action, which involves the antagonism of the P2Y12 receptor, a key player in the platelet activation pathway. Itazigrel is typically administered in a pharmaceutical formulation, and its efficacy and safety profile have been evaluated in clinical studies. The compound's pharmacokinetics, including absorption, distribution, metabolism, and excretion, are essential for determining its therapeutic use and dosing regimens. Additionally, like many antiplatelet agents, Itazigrel may have potential side effects, including bleeding risks, which necessitate careful patient monitoring. Overall, Itazigrel represents a significant advancement in the management of thrombotic disorders, contributing to improved patient outcomes in cardiovascular health.
Formula:C18H14F3NO2S
InChI:InChI=1S/C18H14F3NO2S/c1-23-13-7-3-11(4-8-13)15-16(25-17(22-15)18(19,20)21)12-5-9-14(24-2)10-6-12/h3-10H,1-2H3
InChI key:InChIKey=CIPBQTCSXVEDSG-UHFFFAOYSA-N
SMILES:C(F)(F)(F)C1=NC(=C(S1)C2=CC=C(OC)C=C2)C3=CC=C(OC)C=C3
Synonyms:- Itazigrel
- Thiazole, 4,5-bis(4-methoxyphenyl)-2-(trifluoromethyl)-
- 4,5-Bis(4-methoxyphenyl)-2-(trifluoromethyl)thiazole
- U 53059
- LY 108048
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
Itazigrel
CAS:Itazigrel is a platelet aggregation inhibitor.Formula:C18H14F3NO2SColor and Shape:SolidMolecular weight:365.37
